Health News Roundup: Germany extends COVID curbs as infections threaten infrastructure; U.S. COVID peak may be over but not the pain as deaths rise and more

The FDA action will involve revising the emergency use authorizations for the monoclonal antibodies, the report said, citing two senior administration health officials. Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests The following is a summary of some recent studies on COVID-19.


Devdiscourse News Desk | Updated: 25-01-2022 02:27 IST | Created: 25-01-2022 02:26 IST
Health News Roundup: Germany extends COVID curbs as infections threaten infrastructure; U.S. COVID peak may be over but not the pain as deaths rise and more
Representative image Image Credit: ANI

Following is a summary of current health news briefs.

Germany extends COVID curbs as infections threaten infrastructure

Germany on Monday extended its current pandemic measures as the experts panel appointed by the government has warned the fast spreading Omicron coronavirus variant could bring critical infrastructure in Europe's biggest economy to a breaking point. Chancellor Olaf Scholz said he had agreed with the heads of the federal states to extend restrictions such as limiting private gatherings to 10 ten people and requiring proof of booster vaccination or a negative test at restaurants.

U.S. COVID peak may be over but not the pain as deaths rise

Even as COVID-19 cases drop and hospitalizations show signs of plateauing in hard-hit pockets of the United States, the still-rising death toll from the Omicron variant highlights the trail of loss that follows every virus surge. Coronavirus deaths hit an 11-month high on Sunday, climbing 11% in the past week when compared to the prior week, according to a Reuters.

U.S. FDA to restrict use of Regeneron, Lilly COVID antibody drugs - WaPo

The U.S. Food and Drug Administration (FDA) is likely to restrict the use of COVID-19 antibody treatments from Regeneron and Eli Lilly as they are ineffective against the Omicron variant, the Washington Post reported on Monday. The FDA action will involve revising the emergency use authorizations for the monoclonal antibodies, the report said, citing two senior administration health officials.

Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Omicron survives longer on plastic and skin

COVID drives record annual decline in Canadians' life expectancy -Statscan

COVID-19 contributed to the biggest annual reduction in life expectancy on record in Canada in 2020, the first year of the pandemic, Statistics Canada said in preliminary findings released on Monday. While COVID was the third-leading cause of deaths in 2020, Statscan said the impact from the pandemic also likely contributed indirectly with a rise in deaths due to factors such as delayed medical procedures and increased drug-use.

France reports close to 400 COVID-related deaths

Almost 400 people in France who were hospitalised due to a COVID-19 infection died over the past 24 hours, official data showed on Monday, a value not seen since April. The death toll in French hospitals on Monday rose by 393 to 101,723.

Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found. The study found that CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants, researchers from Brazil and Oxford University said https://www.ox.ac.uk/news/2022-01-24-mixed-vaccine-schedules-offer-strong-booster-responses-after-two-doses-coronavac on Monday.

U.S. CDC warns against travel to Peru, Kuwait, UAE over COVID

The U.S. Centers for Disease Control and Prevention (CDC) on Monday advised against travel to 15 countries and territories because of a rising number of COVID-19 cases. The CDC elevated its travel recommendation to "Level Four: Very High" for Colombia, Costa Rica, Dominican Republic, Fiji, Jamaica, Guadeloupe, Kuwait, Mongolia, Niger, Peru, Romania, Saint Barthelemy, Saint Martin, Tunisia and United Arab Emirates.

Australia COVID-19 deaths mount as return to school threatens new Omicron peak

Australia recorded another surge of COVID-19 deaths on Monday as an outbreak of the highly contagious Omicron variant peaked, and authorities warned numbers could rise further when schools return from end-of-year holidays next week. The world No. 13 economy is trying to strike a balance between reopening after two years of movement restrictions and coping with the highest numbers of deaths and cases of the pandemic.

Do not assume COVID pandemic reaching 'end game', warns WHO

The head of the World Health Organization (WHO) warned on Monday that it was dangerous to assume the Omicron variant would herald the end of COVID-19's acutest phase, exhorting nations to stay focused to beat the pandemic. "It’s dangerous to assume that Omicron will be the last variant and that we are in the end game," Tedros Adhanom Ghebreyesus told a WHO executive board meeting of the two-year pandemic that has killed nearly 6 million people.

(With inputs from agencies.)

Give Feedback